Comprehensive medication guide to Lyrica including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$10–$40 copay for generic pregabalin on most commercial plans (Tier 2–3); brand Lyrica almost always requires prior authorization and step therapy. Medicare Part D covers generic pregabalin with variable copays depending on plan tier.
Estimated Cash Pricing
$330–$450 retail for generic pregabalin without a discount; as low as $14 with a GoodRx coupon or $11 with SingleCare for a 30-day supply. Brand Lyrica retails at $600+ per month.
Medfinder Findability Score
75/100
Summarize with AI
On this page
Lyrica is the brand name for pregabalin, an anticonvulsant and analgesic medication approved by the FDA in December 2004. It belongs to the class of gamma-aminobutyric acid (GABA) analogs and is classified as a Schedule V controlled substance by the DEA. Generic pregabalin has been available in the United States since July 2019.
Lyrica is FDA-approved to treat neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia (nerve pain after shingles), spinal cord injury pain, and fibromyalgia. It is also used as adjunctive therapy for partial-onset seizures in adults and children at least 1 month of age. Off-label, it is sometimes prescribed for generalized anxiety disorder.
Pregabalin is available as immediate-release capsules (25 mg to 300 mg), an oral solution (20 mg/mL), and extended-release tablets under the brand Lyrica CR (82.5 mg, 165 mg, 330 mg). Typical starting dose is 150 mg per day in divided doses, with increases up to 300–600 mg per day depending on indication and tolerability.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Despite its structural similarity to GABA, pregabalin does not directly act on GABA receptors. Instead, it binds with high affinity to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces calcium influx into nerve terminals, which in turn decreases the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P.
In neuropathic pain conditions, damaged nerve cells become hyperexcitable — they fire pain signals more often and more intensely than normal. These overactive nerve cells express increased numbers of alpha2-delta subunits, making pregabalin particularly effective in patients with nerve damage. By quieting these overactive channels, pregabalin reduces the frequency and intensity of pain signals reaching the brain.
For seizure management, the same mechanism reduces the abnormal, synchronized electrical activity in the brain that characterizes partial-onset seizures. For fibromyalgia, pregabalin addresses central sensitization — the brain's hypersensitized pain processing that underlies the condition. Unlike opioids, pregabalin does not act on opioid receptors and does not produce opioid-type dependence.
25 mg — capsule
Starting dose for sensitive patients or renal impairment
50 mg — capsule
Low-dose titration step
75 mg — capsule
Common starting strength; 75 mg twice daily = 150 mg/day starting dose
100 mg — capsule
Mid-range dose
150 mg — capsule
Maintenance dose; 150 mg twice daily = 300 mg/day
200 mg — capsule
Higher maintenance dose
225 mg — capsule
Higher maintenance dose
300 mg — capsule
Maximum recommended dose per capsule; twice daily = 600 mg/day maximum
20 mg/mL — oral solution
For patients who cannot swallow capsules; pediatric use
82.5 mg — extended-release tablet
Lyrica CR — once-daily for DPN and PHN
165 mg — extended-release tablet
Lyrica CR — once-daily maintenance
330 mg — extended-release tablet
Lyrica CR — maximum once-daily dose
Generic pregabalin is not on the FDA's official drug shortage list as of 2026. Since Pfizer's patent expired in July 2019, multiple generic manufacturers have been producing pregabalin, providing robust supply redundancy. The medication is stocked at virtually every major pharmacy chain and independent pharmacy in the United States.
However, patients do encounter localized availability problems. Because pregabalin is a Schedule V controlled substance, pharmacies manage their inventory differently than non-scheduled drugs. Specific strengths may be temporarily out of stock at an individual pharmacy due to ordering cycles, high local demand, or distributor issues. Insurance step therapy requirements and early refill blocks also create access friction, even when physical supply is adequate.
If you are having trouble finding pregabalin in stock at your pharmacy, medfinder can help. medfinder calls pharmacies near you to find which ones can fill your prescription today, then texts you the results — saving you the time and frustration of calling around yourself.
Because pregabalin is a Schedule V controlled substance, any DEA-licensed prescriber can legally prescribe it. This includes physicians, nurse practitioners (in most states), and physician assistants with appropriate DEA registration. No special controlled substance waiver or certification beyond a standard DEA registration is required for Schedule V medications.
The following provider types commonly prescribe pregabalin:
Primary care physicians (PCPs) — for diabetic neuropathy and fibromyalgia
Neurologists — for seizure management and neuropathic pain
Pain management specialists — for chronic neuropathic pain
Rheumatologists — for fibromyalgia
Endocrinologists — for diabetic peripheral neuropathy management
Nurse practitioners (NPs) and physician assistants (PAs) with DEA registration
Pregabalin can be prescribed via telehealth in many cases, as Schedule V medications are generally permissible for telehealth prescribing. However, platform policies and state regulations vary — check with the telehealth service in advance. Many patients successfully manage stable pregabalin prescriptions entirely through telehealth follow-up appointments.
Yes. Pregabalin (Lyrica, Lyrica CR) is a Schedule V controlled substance under the federal Controlled Substances Act, as classified by the Drug Enforcement Administration (DEA). Schedule V is the lowest schedule for federally controlled substances, indicating a recognized but low potential for abuse compared to Schedule I–IV drugs.
Pregabalin was placed in Schedule V because a small percentage of clinical trial participants (~4%) reported euphoria. It is not classified as a narcotic (opioid). Practically, Schedule V status means: prescriptions may have limits on refills in some states, early refills may be blocked by insurance or pharmacy systems, and transferring a pregabalin prescription between pharmacies may have state-specific restrictions. Always carry your prescription information when traveling.
Note: Gabapentin (the most common alternative to pregabalin) is not federally scheduled, although some states have placed it under monitoring programs. This is one reason gabapentin is often preferred by insurance plans as a step therapy requirement before pregabalin.
The most commonly reported side effects of pregabalin include:
Dizziness (up to 30% of patients)
Drowsiness/somnolence (about 23% of patients)
Dry mouth
Weight gain and peripheral edema (swelling of hands/feet)
Blurred vision
Poor coordination (ataxia)
Memory problems, difficulty concentrating
Fatigue
Serious side effects requiring immediate medical attention:
Angioedema — swelling of the face, lips, tongue, or throat (stop pregabalin and call 911)
Respiratory depression — slow or shallow breathing, especially with opioids or CNS depressants
Suicidal thoughts or behavior (boxed warning for all antiepileptic drugs)
Severe allergic reactions (hives, blisters, difficulty breathing)
Know what you need? Skip the search.
Gabapentin (Neurontin)
Most similar mechanism (gabapentinoid); not federally controlled; requires higher doses (300–1,200 mg TID); slower titration; often preferred by insurance for step therapy.
Duloxetine (Cymbalta)
SNRI antidepressant; FDA-approved for DPN and fibromyalgia; also treats depression and anxiety; not controlled; noninferior to pregabalin for diabetic neuropathic pain in clinical trials.
Amitriptyline
Tricyclic antidepressant; effective for neuropathic pain at low doses (10–25 mg QHS); not controlled; more side effects than newer agents; caution in elderly.
Carbamazepine (Tegretol)
Standard for trigeminal neuralgia; useful for specific seizure types; requires blood level monitoring; many drug interactions.
Prefer Lyrica? We can find it.
Opioids (oxycodone, fentanyl, hydrocodone)
majorAdditive CNS and respiratory depression; FDA warning for life-threatening breathing problems; use with extreme caution or avoid.
Benzodiazepines (lorazepam, alprazolam, diazepam)
majorAdditive CNS depression and sedation; increases risk of respiratory depression.
Alcohol
majorEnhanced CNS depression; significantly worsens dizziness and sedation; avoid entirely.
ACE inhibitors (lisinopril, enalapril, captopril)
majorAdditive risk of angioedema (dangerous facial/throat swelling); monitor closely.
Pioglitazone (Actos) / Rosiglitazone (Avandia)
moderateSignificantly increased peripheral edema and weight gain; may precipitate heart failure.
Gabapentin
moderateSame mechanism of action; no therapeutic benefit from combining; only additive side effects.
Lyrica (pregabalin) is a well-established medication that has helped millions of patients manage difficult-to-treat conditions like diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and partial-onset seizures. Since generic availability in July 2019, the cost barrier has dropped dramatically — with coupons, the monthly cost can be as low as $14. The drug is not in a national shortage, and the multi-manufacturer generic supply chain provides good stability.
The main challenges patients face are access-related rather than supply-related: Schedule V restrictions that create early refill friction, insurance step therapy requiring gabapentin trials first, and individual pharmacy stock gaps for specific strengths. Most of these obstacles can be navigated with preparation, the right savings tools, and proactive communication with your prescriber and pharmacist.
If you're struggling to find your Lyrica prescription in stock, medfinder can take the hassle out of the search. Tell us your medication, dose, and location — we'll call pharmacies near you and text you which ones can fill your prescription today.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini